199
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Crystal structure and antibacterial properties of a new dinuclear copper complex based on an unsymmetrical NN′O type Schiff base ligand

&
Pages 154-163 | Received 13 Oct 2019, Accepted 14 Jan 2020, Published online: 13 Feb 2020
 

Abstract

A new dinuclear copper(II) Schiff base complex, [Cu2L2(H2O)2(µ-ClO4)]ClO4, was synthesized and characterized by single crystal X-ray crystallography, FT-IR and UV-Vis spectroscopy, and elemental analysis. In this complex, L−1 is the deprotonated form of N-5-bromosalicylidene-1,3-propanediamine. Single crystals of the complex were crystallized in the monoclinic crystal system and P21/n space group. The geometry around each metal center is distorted octahedral in which the monoanionic Schiff base ligand has occupied three apices of the octahedron and the other three apices are occupied by a water molecule, an oxygen atom of the µ-perchlorato anion, and a phenoxo type oxygen atom from the other Schiff base ligand. Antibacterial properties of the synthesized complex have been investigated against human pathogenic bacteria, such as Escherichia coli, Klebsiella pneumonia, Salmonella (sp) and Proteus (sp), and Staphylococcus aureus. The complex showed moderate antibacterial activity against both Gram-type bacteria with the highest activity against K. pneumonia and E. coli.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.